Fu Ren Pharmaceutical Group Co., Ltd. is a comprehensive group company with pharmaceutical and wine industries as its leading industries and integrating R&D, production, operation, investment and management. It owns Furen Pharmaceutical Group Pharmaceutical Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Kaifeng Pharmaceutical (Group) Co., Ltd., Kaifeng Yugang Pharmaceutical Co., Ltd., Henan Furen Huaiqingtang Pharmaceutical Co., Ltd., and Henan Yuyuan Pharmaceutical Co., Ltd. , Furen Pharmaceutical Technology Development Co., Ltd., Henan Songhe Liquor Co., Ltd. and the listed company Shanghai Furen Industrial (Group) Co., Ltd. and many other wholly-owned and holding subsidiaries. The products cover many categories such as Chinese and Western medicine preparations, biochemical pharmaceuticals, biopharmaceuticals, and raw materials.
Currently, Fu Ren has formed more than 20 dosage forms including water injection, powder injection, freeze-dried powder injection, capsules, tablets, granules, oral liquid, drops, and gels, with nearly 1,000 products. The number of varieties, dosage forms and varieties ranks among the top in the country. It can produce 5.2 billion water injections, 1.2 billion powder injections, 200 million freeze-dried powder injections, 15 billion tablets and capsules, 600 million bags of granules, 1,000 tons of glue, and 50 million large infusions annually. bags, 1 billion oral liquids, and 2,500 tons of raw materials. Its comprehensive production capacity of preparations ranks among the top in the country. The "Fu Ren" trademark was recognized as a famous trademark.
In the latest 307 "National Essential Drugs List", Furen was selected into 170 varieties, accounting for 55% of the total list; in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2009) In the 2016 edition, Furen was selected into 413 varieties (including 3 exclusive varieties), including 255 Category A varieties and 158 Category B varieties. Become the pharmaceutical company with the largest variety among Chinese pharmaceutical companies selected in the 2009 edition of the "Catalogue"!
Furen has always been adhering to the corporate mission of "Common People's Medicine Made by Furen" and proposed the initial corporate positioning of "China's manufacturer of global generic drugs". It has established a leading profit model with "multiple varieties as the core, large production capacity as the foundation, large marketing as support, and driving the establishment of a big Furen brand". Implement the quality management policy of "output gives way to quality, cost gives way to quality"; take "specialization, professionalism and concentration" as the development orientation of the industry. In line with the business philosophy of "harmony without diversity wins the world", we are inclusive, respectful of laws, and practice rules. While sharing the benefits brought by globalization, we strengthen the company's strategic vision and grasp of the future. To date, Furen Pharmaceutical Group has formed a production capacity of 800 million cephalosporin preparations and 11 products. It has been recognized as a "Key High-tech Enterprise of the National Torch Plan" by the Ministry of Science and Technology. The company's products are exported to more than 70 countries and regions including Europe, Southeast Asia, and Hong Kong. In addition, the overall scale of Furen Pharmaceutical Group has more than 500 varieties of Chinese and Western medicine preparations such as capsules, granules, tablets, oral liquids, pills, etc., and the number of varieties ranks among the top in the national industry; among them, tablets and capsules are The production capacity is 12 billion capsules/tablet, ranking among the top in the country. In 2006, the group's comprehensive preparation production capacity will rank among the top in the country.
“Harmony but difference, win the world” Furen Pharmaceutical Group maintains its brand personality externally and integrates it with the overall market development, but it also adopts different brand advantage competition strategies, thus It makes a distinction between uniqueness and originality, forming a win-win situation with mutual development. Furen Pharmaceutical Group is based on the development goal of being the largest supplier of generic drugs in China, establishing research and development patents, production scale, product branding, management innovation, and market internationalization; establishing competitiveness with harmonious but different corporate development personalities guarantee system; establish a scientific and systematic human resources system; build a research and development system. Furen Pharmaceutical Group has gradually emerged as an international modern enterprise focusing on the production of generic drugs.
"People's medicine, made by Fu Ren". Furen Pharmaceutical Group's eight-year leap has created such a mature platform with big brands, large production capacity, and large networks as its core; a platform that attracts pharmaceutical R&D units at the forefront of the industry to join in and cooperate; a platform from R&D to production , efficient and fast operation system for sales.
With the help of this platform, patented technology pharmaceutical products can be quickly launched, greatly reducing operating costs, becoming affordable, willing to buy, accessible and effective products that the people can afford, and ultimately benefiting society. This is also the profound meaning of "people's medicine, made by Fu Ren". The corporate mission of Baixinyao and Furenzao was established, and the initial corporate positioning of a Chinese manufacturer of global generic drugs was proposed. It has established a leading profit model with multiple varieties as the core, large production capacity as the basis, and large marketing as support, driving the establishment of the Furen brand.
In line with the business philosophy of being harmonious but different and winning the world together, we are inclusive, respect the laws and practice the rules, and strengthen the company's strategic vision and vision for the future while sharing the benefits brought by globalization. grasp.